Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bacterin International announces Clinical Results on use of Bacterin's OsteoSponge for Foot and Ankle Arthrodeses Procedures

Thursday, 20 Mar 2014 07:30am EDT 

Bacterin International Holdings Inc:Results utilizing OsteoSponge bone graft for foot and ankle arthrodeses procedures has been published in the peer-reviewed journal Orthopedics.Article reports prospective analysis of 25 patients who underwent foot and ankle arthrodesis involving 45 total joints.Results indicated that 96 pct of patients showed radiographic fusion at 6 and 12 months (24/25 patients) postoperative assessment, with 97.4 pct overall fusion rate (44 out of 45 joints fused).Pain was assessed pre and postoperatively via visual analog scale (VAS), with statistically significant improvements at 6 and 12 months relative to preoperative pain scores.Functional outcomes were significantly improved at 6 and 12 months compared with preoperative assessment according to American Orthopaedic Foot and Ankle Society (AOFAS) scores. 

Company Quote

-0.1 -3.29%
28 Nov 2014